Literature DB >> 30115335

Emergence of Global Antibiotic Resistance.

Martha Shawn Morehead1, Catherine Scarbrough2.   

Abstract

Antibiotic resistance is a worldwide phenomenon and a global public health crisis. The inappropriate use of antibiotics in the human, animal, food, and agricultural arenas have contributed to the current dilemma. Both gram-positive and gram-negative resistant bacteria have been deemed serious and urgent threats by the Centers for Disease Control and Prevention. The World Health Organization has created a 5-objective global action plan to address antimicrobial resistance and to coordinate numerous international sectors. Antibiotic resistance affects both this generation and the next; thus, related ethical challenges, such as patient autonomy and justice have yet to be fully understood.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Antibiotic stewardship; CDC bacterial threats; Global health; Gram-negative bacteria; Gram-positive bacteria; WHO global action plan

Mesh:

Substances:

Year:  2018        PMID: 30115335     DOI: 10.1016/j.pop.2018.05.006

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  30 in total

Review 1.  Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design.

Authors:  Rya Ero; Veerendra Kumar; Weixin Su; Yong-Gui Gao
Journal:  Protein Sci       Date:  2019-03-04       Impact factor: 6.725

2.  Why have Non-communicable Diseases been Left Behind?

Authors:  Florencia Luna; Valerie A Luyckx
Journal:  Asian Bioeth Rev       Date:  2020-03-20

3.  The effects of antidepressants fluoxetine, sertraline, and amitriptyline on the development of antibiotic resistance in Acinetobacter baumannii.

Authors:  Suna Sibel Gurpinar; Didem Kart; Mujde Eryilmaz
Journal:  Arch Microbiol       Date:  2022-03-30       Impact factor: 2.552

4.  Metabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranes.

Authors:  Inga Nilsson; Sheng Y Lee; William S Sawyer; Christopher M Baxter Rath; Guillaume Lapointe; David A Six
Journal:  J Lipid Res       Date:  2020-03-10       Impact factor: 5.922

5.  Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.

Authors:  Samet Ucak; Mert Sudagidan; Baris A Borsa; Banu Mansuroglu; Veli C Ozalp
Journal:  World J Microbiol Biotechnol       Date:  2020-04-25       Impact factor: 3.312

6.  Early Use of Antibiotics Is Associated with a Lower Incidence of Necrotizing Enterocolitis in Preterm, Very Low Birth Weight Infants: The NEOMUNE-NeoNutriNet Cohort Study.

Authors:  Yanqi Li; René Liang Shen; Adejumoke I Ayede; Janet Berrington; Frank H Bloomfield; Olubunmi O Busari; Barbara E Cormack; Nicholas D Embleton; Johannes B van Goudoever; Gorm Greisen; Zhongqian He; Yan Huang; Xiaodong Li; Hung-Chih Lin; Jiaping Mei; Paula P Meier; Chuan Nie; Aloka L Patel; Per T Sangild; Thomas Skeath; Karen Simmer; Signe Uhlenfeldt; Marita de Waard; Sufen Ye; Xuqiang Ye; Chunyi Zhang; Yanna Zhu; Ping Zhou
Journal:  J Pediatr       Date:  2020-06-14       Impact factor: 4.406

Review 7.  The Use of Preoperative Antibiotics in Elective Soft-Tissue Procedures in the Hand: A Critical Analysis Review.

Authors:  Lauren M Shapiro; Thompson Zhuang; Kevin Li; Robin N Kamal
Journal:  JBJS Rev       Date:  2019-08

8.  Is Penicillin-Nonsusceptible Streptococcus pneumoniae a Significant Challenge to Healthcare System? A Systematic Review and Meta-Analysis.

Authors:  Farzad Khademi; Amirhossein Sahebkar
Journal:  Scientifica (Cairo)       Date:  2021-05-27

9.  Synergy of alanine and gentamicin to reduce nitric oxide for elevating killing efficacy to antibiotic-resistant Vibrio alginolyticus.

Authors:  Su-Fang Kuang; Yue-Tao Chen; Jia-Jie Chen; Xuan-Xian Peng; Zhuang-Gui Chen; Hui Li
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

10.  |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.

Authors:  Edgar González-Villalobos; Rosa María Ribas-Aparicio; Gerardo Erbey Rodea Montealegre; Laura Belmont-Monroy; Yerisaidy Ortega-García; Gerardo Aparicio-Ozores; José Luis Balcázar; Carlos Alberto Eslava-Campos; Ulises Hernández-Chiñas; José Molina-López
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.